American Cancer Society Cancer Action Network

Cancer Drug Parity Act Gains Strong Support from Leading Healthcare Organizations

Retrieved on: 
Mittwoch, November 8, 2023
EBP, Insurance, Attention, ONS, Act, AIM, Public policy, International Myeloma Foundation, IV, Congress, House, Legislation, Face, IMF, RN, Multiple myeloma, CLL, AIM at Melanoma Foundation, Disease, Melanoma, DNP, ACS, Representative, Parity, Oncology Nursing Society, Association of American Cancer Institutes, Cancer, American Cancer Society Cancer Action Network, Oral cancer, Patient, ASCO, Lymphoma, Health insurance, Pharmaceutical industry, Nursing, Dietary supplement

The International Myeloma Foundation (IMF), which leads the Coalition to Improve Access to Cancer Care (CIACC), fervently supports the Cancer Drug Parity Act, recognizing its profound impact on myeloma patients and their families.

Key Points: 
  • The International Myeloma Foundation (IMF), which leads the Coalition to Improve Access to Cancer Care (CIACC), fervently supports the Cancer Drug Parity Act, recognizing its profound impact on myeloma patients and their families.
  • The Cancer Drug Parity Act would put the needs of patients first to ensure that patients, along with their healthcare providers, can choose the treatment option they deem is most appropriate”.
  • ONS is proud to support the Cancer Drug Parity Act and commends the bill’s sponsors for their leadership in ensuring parity for oral cancer treatments.”
    Recognizing the pressing need for equitable access to cancer treatments, Lisa Lacasse, president of the American Cancer Society Cancer Action Network (ACS CAN), emphasized the critical issue of disparities in cost-sharing for oral chemotherapy medications.
  • For more information on the Cancer Drug Parity Act and its potential impact on cancer care, please visit https://www.access2cancercare.org/ .

HARD ROCK HOTEL & CASINO ATLANTIC CITY'S ANNUAL PINKTOBER CAMPAIGN RAISES OVER $164,000 FOR AMERICAN CANCER SOCIETY

Retrieved on: 
Donnerstag, November 9, 2023
American Cancer Society, Hard Rock Live (Atlantic City), Research, Breast cancer, Breast Cancer Awareness Month, Sereboff v. Mid Atlantic Medical Services, Inc., American Cancer Society Cancer Action Network, Hard Rock Cafe, Hard Rock Live, Casino, Hard Rock Hotel & Casino Atlantic City

ATLANTIC CITY, N.J., Nov. 9, 2023 /PRNewswire/ -- Hard Rock Hotel & Casino Atlantic City raised over $164,000 through their annual Pinktober initiative, ranking the resort nationally as the No.1 fundraising team by the American Cancer Society. Pinktober is a part of the Hard Rock Heals Foundation, the charitable arm of Hard Rock International, with proceeds benefiting American Cancer Society to support breast cancer awareness and research. To date, Hard Rock International has raised more than $10 million since the inception of Pinktober 23 years ago including $1.2 million raised in 2022. The funds raised by Hard Rock Atlantic City will benefit the American Cancer Society's mission locally.

Key Points: 
  • ATLANTIC CITY, N.J., Nov. 9, 2023 /PRNewswire/ -- Hard Rock Hotel & Casino Atlantic City raised over $164,000 through their annual Pinktober initiative, ranking the resort nationally as the No.1 fundraising team by the American Cancer Society.
  • Pinktober is a part of the Hard Rock Heals Foundation, the charitable arm of Hard Rock International, with proceeds benefiting American Cancer Society to support breast cancer awareness and research.
  • The funds raised by Hard Rock Atlantic City will benefit the American Cancer Society's mission locally.
  • "Hard Rock Atlantic City is honored to raise awareness and funds through our Pinktober initiative to support our community and the American Cancer Society," said George Goldhoff, President of Hard Rock Hotel & Casino Atlantic City.

New Canadian Cancer Statistics report reveals lung cancer death rates are declining faster than any other cancer type in Canada

Retrieved on: 
Mittwoch, November 8, 2023
Tobacco industry, Survival, Cervical cancer, Incidence, American Cancer Society, Government, Statistics Canada, Lung cancer, American Cancer Society Cancer Action Network, Mortality, Prevalence, CCS, Tobacco smoking, Legislation, Workplace, News, Air pollution, Probability, Statistics, Research, HIV disease progression rates, CAT, Smoking, Tobacco, Surveillance, Lung, Disease, Risk, Neoplasm, Immune system, Annual report, Medicine, Public Health Agency, Asbestos, Recurrence, Anne, Leukemia, Senior, Cancer, Investment, Public Health Agency of Canada, Patient, Pain, Empathy, Prognosis, Canadian Cancer Society, Acceleration, Dietary supplement, Pharmaceutical industry, Birth control, Uranium mining, Medical imaging

The annual report – Canadian Cancer Statistics 2023 – was developed by the Canadian Cancer Statistics Advisory Committee in collaboration with CCS, Statistics Canada and the Public Health Agency of Canada.

Key Points: 
  • The annual report – Canadian Cancer Statistics 2023 – was developed by the Canadian Cancer Statistics Advisory Committee in collaboration with CCS, Statistics Canada and the Public Health Agency of Canada.
  • While the age-standardized lung cancer death rates have decreased substantially, an estimated 20,600 people are expected to die from lung cancer (9,800 females and 10,800 males) in Canada in 2023.
  • The most significant reason that lung cancer death rates are improving is due to a reduction in commercial tobacco use, which is the leading risk factor for lung cancer.
  • "By investing more into lung cancer research, we gain critical insights about lung cancer and disease progression that will enable us to develop better treatments for lung cancer patients."

Confusion around lung cancer screening contributes to low screening rates

Retrieved on: 
Mittwoch, November 1, 2023
American Cancer Society, Cervical cancer, History, Lung cancer, Colorectal cancer, News, Prostate cancer, Testicular cancer, Risk, Confusion, Cancer, Breast cancer, DNP, CT, USPSTF, Oral cancer, Skin cancer, American Cancer Society Cancer Action Network, Prevent Cancer Foundation, Mobile phone, Medical imaging, Dairy

Alexandria, Va., Nov. 01, 2023 (GLOBE NEWSWIRE) -- Lung cancer remains the leading cause of cancer death in the U.S. despite effective screening for those at high risk—and significant confusion about who is eligible for lung cancer screening and what screening for the disease looks like may be to blame.

Key Points: 
  • Alexandria, Va., Nov. 01, 2023 (GLOBE NEWSWIRE) -- Lung cancer remains the leading cause of cancer death in the U.S. despite effective screening for those at high risk—and significant confusion about who is eligible for lung cancer screening and what screening for the disease looks like may be to blame.
  • This has resulted in shockingly low screening rates for a cancer that takes more than 127,000 lives in the U.S. every year.1
    The news comes from a recent report from the Prevent Cancer Foundation that found 65% of Americans 21 years of age and older say they are not up to date with one or more routine cancer screenings.2 Of all routine cancer screenings, lung cancer screening rates are the lowest— less than 6% of eligible people in the U.S. have been screened for lung cancer compared to 70% for breast cancer and 74% for colorectal cancer.
  • This spotlighted the confusion surrounding what lung cancer screening is and the lack of understanding around lung cancer screening eligibility.
  • The cancer screenings studied in this survey were for breast cancer, cervical cancer, colorectal cancer, oral cancer, lung cancer, prostate cancer, skin cancer and testicular cancer.

New Report Offers Guidance on Radon Testing Devices Safeguarding Canadians Against Lung Cancer

Retrieved on: 
Mittwoch, November 1, 2023
Smartphone, Associate, American Cancer Society, Reading, Lung cancer, Health Canada, Non-Smokers' Rights Association, Public Health Agency of Canada, Atmosphere, Soybean oil, Risk, Diagnosis, American Cancer Society Cancer Action Network, Simon Fraser University, Uranium mining, Radon

The report offers recommendations to evaluate indoor air quality and safeguard Canadians against lung cancer from radon exposure.

Key Points: 
  • The report offers recommendations to evaluate indoor air quality and safeguard Canadians against lung cancer from radon exposure.
  • "Radon continues to be a leading cause of lung cancer in non-smokers," says Nancy Wirtz, Manager, Cancer Prevention at the Canadian Cancer Society.
  • In October 2021, Winnipeg native Corie Haslbeck received a devastating stage 4 lung cancer diagnosis after being exposed to elevated levels of radon.
  • The first step that Canadians can take to protect themselves against lung cancer is to test their home for radon.

Cinch Home Services Proudly Sponsors Making Strides Against Breast Cancer's Palm Beach County October Event

Retrieved on: 
Mittwoch, Oktober 18, 2023
American Cancer Society, Survivor, Breast Cancer Awareness Month, Research, Walkers, Caregiver, Breast cancer, American Cancer Society Cancer Action Network, Movement, Patient, Birth control, Hospital, Cinch

BOCA RATON, Fla., Oct. 18, 2023 /PRNewswire/ -- Cinch Home Services, one of the nation's leading providers of home service solutions, recently sponsored the Palm Beach County Making Strides Against Breast Cancer walk. The event, hosted by the American Cancer Society on October 14, brought together local community members, businesses, and leadership to join the nation's largest and most impactful breast cancer awareness movement.

Key Points: 
  • BOCA RATON, Fla., Oct. 18, 2023 /PRNewswire/ -- Cinch Home Services , one of the nation's leading providers of home service solutions, recently sponsored the Palm Beach County Making Strides Against Breast Cancer walk.
  • "Cinch is proud to support the Making Strides Against Breast Cancer walk of Palm Beach County," said Steve Upshaw, Cinch CEO.
  • Lindsay Bennett, Senior Development Manager at the American Cancer Society in Palm Beach County, emphasized the importance of sponsors like Cinch Home Services, noting, "The support from our dedicated sponsors like Cinch Home Services is critical to our ongoing fight against breast cancer.
  • To donate to the Cinch team supporting Making Strides Against Breast Cancer of Palm Beach County or learn more about the American Cancer Society, visit the Team Cinch Home Services homepage.

Phoenix Children's Expands Research Team with Scientist Pioneering New Childhood Cancer Treatments

Retrieved on: 
Dienstag, Oktober 17, 2023
Physician, Lung cancer, Pediatric nursing, Doctor of Philosophy, Phoenix Children's Hospital, American Cancer Society, American Cancer Society Cancer Action Network, University of Arizona College of Medicine – Tucson, Cardiology, Neurology, Proton, Pharmacist, Nanoparticle, University, Biostatistics, The Ride to Conquer Cancer, Patient, University of Illinois at Chicago, Nursing, Research, Conquer, Cincinnati Children's Hospital Medical Center, Molecular biology, Medicine, Bangladesh Technical Education Board, Metastasis, Neoplasm, Vinnytsia National Medical University. N. I. Pirogov, Chronic lung disease, Pharmaceutical industry, Dentistry, MD, Cancer

PHOENIX, Oct. 17, 2023 /PRNewswire/ -- Phoenix Children's, one of the nation's fastest-growing pediatric health systems, continues to strengthen its focus on pediatric research with the hire of Tanya Kalin, MD, PhD, a renowned scientist focused on pioneering effective treatments for pediatric cancers with fewer negative side effects for children. Dr. Kalin also serves as vice chair of translational research for the Phoenix Children's Center for Cancer and Blood Disorders, and as a professor of Child Health at the University of Arizona College of Medicine – Phoenix.

Key Points: 
  • Dr. Kalin also serves as vice chair of translational research for the Phoenix Children's Center for Cancer and Blood Disorders , and as a professor of Child Health at the University of Arizona College of Medicine – Phoenix.
  • Dr. Kalin, who assumed her new post in recent weeks, comes to Phoenix Children's from Cincinnati Children's, where she founded and directed her namesake Kalin Research Lab.
  • Two members of her lab also are moving to Phoenix Children's to continue their research with Dr. Kalin.
  • Research underway at Phoenix Children's consists of more than 700 active studies, 640 research investigators and 90 research staff members including research scientists, associates, biostatisticians, pharmacists, nurses, coordinators and assistants.

Stop & Shop Teams Up with American Cancer Society for the 15th Year to Fight Breast Cancer

Retrieved on: 
Mittwoch, Oktober 4, 2023
Survivor, Partnership, Society, Radiation, Life, Friends, EVP, Cancer, Hope, Woman, Public policy, American Cancer Society, Research, Attitude, Sale, Movement, Girl Guides, Stop & Shop, Stop, Patient, Breast cancer, Investment, Jewish Community Relations Council of Minnesota and the Dakotas, Diagnosis, American Cancer Society Cancer Action Network, Rest, Family, Disease, Birth control, Medical imaging, Nursing

This year, Stop & Shop is again joining the American Cancer Society’s movement to celebrate breast cancer survivors and thrivers and help end breast cancer as we know it.

Key Points: 
  • This year, Stop & Shop is again joining the American Cancer Society’s movement to celebrate breast cancer survivors and thrivers and help end breast cancer as we know it.
  • Mary fought her battle with cancer prior to joining Stop & Shop and now advocates for breast cancer research as a survivor.
  • “Stop & Shop is proud to join the American Cancer Society for the fifteenth year to continue supporting the important work the organization does in the fight against breast cancer,” says Jennifer Barr, Director of External Communications and Community Relations for Stop & Shop.
  • Thanks to partners like Stop & Shop, a breast cancer diagnosis does not come without hope, and the breast cancer journey is not one that is traveled alone.

Aitia and Pancreatic Cancer Action Network Partner to Transform De-Identified Multi-Omic Patient Data into Digital Twins to Drive New Discoveries and Improve Patient Outcomes

Retrieved on: 
Mittwoch, September 27, 2023
Pancreatic cancer, Causal AI, Survival, Research, Biomarker, Patient, ACS, Drug combination, American Cancer Society, Digital twin, American Cancer Society Cancer Action Network, Disease, Pharmaceutical industry, SPARK, Causality (physics)

This strategic collaboration marks a significant milestone for Aitia, reinforcing its commitment to expanding its impact and accelerating the discovery and development of new drugs in pancreatic cancer.

Key Points: 
  • This strategic collaboration marks a significant milestone for Aitia, reinforcing its commitment to expanding its impact and accelerating the discovery and development of new drugs in pancreatic cancer.
  • Pancreatic cancer, responsible for over 466,003 global deaths in 2020 according to Global Cancer Statistics , is showing promising progress.
  • The American Cancer Society's (ACS) Cancer Facts & Figures 2023 report reveals an all-time high five-year survival rate of 12% for pancreatic cancer.
  • "Our collaboration with Aitia opens new doors to cutting-edge research and development, offering hope to pancreatic cancer patients and their families.

September is Prostate Cancer Awareness Month: Know the Warning Signs, When to Get Screened and Important New Treatments

Retrieved on: 
Mittwoch, August 30, 2023
Human, Prostate-specific antigen, Radiation, National Prostate Health Month, Biopsy, Prostate cancer, Survival, Urethra, Urination, Cancer, Breast, Research, Risk, Mortality, Prostate, Immunotherapy, Science, Pain, Death, Incidence, Estate (law), ACS, IMPACT, Blood, Ejaculation, American Cancer Society, Breast cancer, Smoking, White, PSA, Disease, American Cancer Society Cancer Action Network, Dairy, Birth control, Medical imaging

ATLANTA, Aug. 30, 2023 /PRNewswire/ -- Prostate cancer is the second leading cause of cancer death among men in the United States. According to the latest research from scientists at the American Cancer Society (ACS), more than 288,000 men will be diagnosed with the disease this year, with close to 35,000 deaths. Black men are two times more likely to die from the disease than White men and have the highest death rate for prostate cancer of any racial and ethnic group. However, when prostate cancer is detected early, the odds of survival are high. In fact, more than 3.5 million men diagnosed with the disease in the U.S. are still alive today.

Key Points: 
  • Renowned prostate cancer researcher Dr. Lorelei Mucci is the director of strategic research partnerships at the American Cancer Society.
  • Her role includes leading an ACS initiative called IMPACT , or "Improving Mortality Toward Prostate Cancer Together" to address the alarming negative trends in prostate cancer incidence and disparities.
  • For Prostate Cancer Awareness Month Dr. Mucci reviews the signs and symptoms of prostate cancer, including important information about risk factors, PSA screening, and more:
    1-Why is it important every September during Prostate Cancer Awareness Month to help people learn about the disease?
  • Prostate Cancer Awareness Month is so important to have a focused time for men and their families to share knowledge, experiences, and state of science on this important cancer.